Regulation by mir181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma

Journal of the National Cancer Institute

Volumn 106, Issue 11, 2014, Pages

  Gibert, Benjamin ^a   Delloye Bourgeois, Céline ^a   Gattolliat, Charles Henry ^b,g   Meurette, Olivier ^a   Le Guernevel, Solen ^a   Fombonne, Joanna ^a   Ducarouge, Benjamin ^a   Lavial, Fabrice ^a   Bouhallier, Frantz ^c   Creveaux, Marion ^a   Negulescu, Ana Maria ^a   Bénard, Jean ^b   Janoueix Lerosey, Isabelle ^d   Harel Bellan, Annick ^e,f   Delattre, Olivier ^d   Mehlen, Patrick ^a  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b UMR 8126   (France)

^c STEM CELL AND BRAIN RESEARCH INSTITUTE   (France)

^d INSTITUT CURIE   (France)

^e CNRS   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CASPASE 3; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE RELATED DOWNREGULATED BY ONCOGENE; MICRORNA; MICRORNA 181; UNCLASSIFIED DRUG; CDON PROTEIN, HUMAN; MIRN181 MICRORNA, HUMAN; SONIC HEDGEHOG PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL DEATH; CELL ONCOGENE; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW RISK POPULATION; MAJOR CLINICAL STUDY; NEUROBLASTOMA; NEUROBLASTOMA CELL LINE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; GENETICS; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

APOPTOSIS; CELL ADHESION MOLECULES; HEDGEHOG PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; NEUROBLASTOMA; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 84922479996     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju318     Document Type: Article

References (34)

1. Ambros IM, Benard J, Boavida M, et al. Quality assessment of genetic markers used for therapy stratification. J Clin Oncol. 2003;21(11):2077-2084.
2. Maris JM, Matthay KK Molecular biology of neuroblastoma. J Clin Oncol. 1999;17(7):2264-2279.
3. Mehlen P, Delloye-Bourgeois C, Chedotal A. Novel roles for Slits and netrins: axon guidance cues as anticancer targets? Nat Rev Cancer. 2011;11(3):188-197.
4. Mehlen P, Bredesen DE Dependence receptors: from basic research to drug development. Sci Signal. 2011;4(157):mr2.
5. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6(6):449-458.
6. Castets M, Broutier L, Molin Y, et al. DCC constrains tumour progression via its dependence receptor activity. Nature. 2012;482(7386):534-537.
7. Delloye-Bourgeois C, Fitamant J, Paradisi A, et al. Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med. 2009;206(4):833-847.
8. Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, et al. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest. 2010;120(3):850-858.
9. Grady WM. Making the case for DCC and UNC5C as tumor-suppressor genes in the colon. Gastroenterology. 2007;133(6):2045-2049.
10. Genevois AL, Ichim G, Coissieux MM, et al. Dependence receptor TrkC is a putative colon cancer tumor suppressor. Proc Natl Acad Sci U S A. 2013;110(8):3017-3022.
11. Grady WM. Context is everything for dependence receptors in colorectal cancer. Proc Natl Acad Sci U S A. 2013;110(8):2697-2698.
12. Tenzen T, Allen BL, Cole F, et al. The cell surface membrane proteins Cdo and Boc are components and targets of the Hedgehog signaling pathway and feedback network in mice. Dev Cell. 2006;10(5):647-656.
13. Zhang W, Kang JS, Cole F, et al. Cdo functions at multiple points in the Sonic Hedgehog pathway, and Cdo-deficient mice accurately model human holoprosencephaly. Dev Cell. 2006;10(5):657-665.
14. Kang JS, Mulieri PJ, Miller C, et al. CDO, a robo-related cell surface protein that mediates myogenic differentiation. J Cell Biol. 1998;143(2):403-413.
15. Kang JS, Mulieri PJ, Hu Y, et al. BOC, an Ig superfamily member, associates with CDO to positively regulate myogenic differentiation. EMBO J. 2002;21(1-2):114-124.
16. Martinelli DC, Fan CM Gas1 extends the range of Hedgehog action by facilitating its signaling. Genes Dev. 2007;21(10):1231-1243.
17. Allen BL, Song JY, Izzi L, et al. Overlapping Roles and Collective Requirement for the Coreceptors GAS1, CDO, and BOC in SHH Pathway Function. Dev Cell. 2011;20(6):775-787.
18. Izzi L, Levesque M, Morin S, et al. Boc and gas1 each form distinct shh receptor complexes with ptch1 and are required for shh-mediated cell proliferation. Dev Cell. 2011;20(6):788-801.
19. Mehlen P, Rabizadeh S, Snipas SJ, et al. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 1998;395(6704):801-804.
20. Delloye-Bourgeois C, Gibert B, Rama N, et al. Sonic Hedgehog promotes tumor cell survival by inhibiting CDON pro-apoptotic activity. PLoS Biol. 2013;11(8):e1001623.
21. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203-216.
22. Stupack DG, Teitz T, Potter MD, et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 2006;439(7072):95-99.
23. McLellan JS, Zheng X, Hauk G, et al. The mode of Hedgehog binding to Ihog homologues is not conserved across different phyla. Nature. 2008;455(7215):979-983.
24. Wang Q, Diskin S, Rappaport E, et al. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res. 2006;66(12):6050-6062.
25. Guo C, White PS, Weiss MJ, et al. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene. 1999;18(35):4948-4957.
26. Gattolliat CH, Thomas L, Ciafre SA, et al. Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer. 2011;105(9):1352-1361.
27. Taylor MA, Sossey-Alaoui K, Thompson CL, et al. TGF-beta upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest. 2013;123(1):150-163.
28. Chen Y, Stallings RL Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007;67(3):976-983.
29. Bao BY, Pao JB, Huang CN, et al. Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy. Clin Cancer Res. 2011;17(4):928-936.
30. Nishimura J, Handa R, Yamamoto H, et al. microRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep. 2012;28(6):2221-2226.
31. Pichler M, Winter E, Ress AL, et al. miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor. J Clin Pathol. 2013;67(3)198-203.
32. Mehlen P, Fearon ER Role of the dependence receptor DCC in colorectal cancer pathogenesis. J Clin Oncol. 2004;22(16):3420-3428.
33. Luo Y, Kaz AM, Kanngurn S, et al. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer. PLoS Genet. 2013;9(7):e1003552.
34. Laneve P, Di Marcotullio L, Gioia U, et al. The interplay between micro-RNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc Natl Acad Sci U S A. 2007;104(19):7957-7962.